Latest Thrombosis Stories
The Firm is evaluating Xarelto lawsuits on behalf of individuals who suffered life-threatening internal bleeding, stroke, deep vein thrombosis, pulmonary embolism, or other serious injuries allegedly
Provides Another Important and Highly Complex Injectable to Complement Mylan Institutional's Growing Portfolio in the U.S. PITTSBURGH, Sept. 10, 2014 /PRNewswire/ -- Mylan Inc.
BARCELONA, Spain, September 2, 2014 /PRNewswire/ -- -- GARFIELD-AF Registry presentations at ESC CONGRESS 2014 provide insight into treatment and outcomes of patients
X-VeRT Study Results Presented as a Hot Line Session at the ESC Congress 2014 and Published in European Heart Journal BARCELONA, Spain, Sept.
Aspirin may be a promising alternative for those who can’t take long-term anticoagulant drugs that prevent clots from reoccurring in the veins
Hot Line session presentations to feature renal function data from pivotal RE-LY® trial and global GLORIA(TM)-AF registry updates RIDGEFIELD, Conn., Aug.
Randy Fenninger to Lead Organization With Strategic Focus Aimed at Increasing Recognition of Life-Threatening Blood Clots and Their Impact on Public Health Rockville,
- A trick or prank.